1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 29242966 | CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine. | 2018 Feb | 1 |